Stroke · adults in sinus rhythm after cardioversion of atrial fibrillation
Quinidine showed no clear difference in stroke compared with placebo or no treatment (low certainty).
1 finding from 1 review
Recurrence of atrial fibrillation · adults in sinus rhythm after cardioversion of atrial fibrillation
Dronedarone probably leads to lower recurrence of atrial fibrillation compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
All‐cause mortality · adults in sinus rhythm after cardioversion of atrial fibrillation
Sotalol leads to higher all‐cause mortality compared with placebo or no treatment (high certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults in sinus rhythm after cardioversion of atrial fibrillation
Sotalol probably leads to higher withdrawals due to adverse effects compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Proarrhythmia · adults in sinus rhythm after cardioversion of atrial fibrillation
Sotalol probably leads to higher proarrhythmia compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Stroke · adults in sinus rhythm after cardioversion of atrial fibrillation
Sotalol showed no clear difference in stroke compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Recurrence of atrial fibrillation · adults in sinus rhythm after cardioversion of atrial fibrillation
Sotalol leads to lower recurrence of atrial fibrillation compared with placebo or no treatment (high certainty).
1 finding from 1 review
Recurrence of atrial fibrillation · adults in sinus rhythm after cardioversion of atrial fibrillation
Quinidine leads to lower recurrence of atrial fibrillation compared with placebo or no treatment (high certainty).
1 finding from 1 review
All‐cause mortality · adults in sinus rhythm after cardioversion of atrial fibrillation
It is very uncertain whether disopyramide changes all‐cause mortality compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · adults in sinus rhythm after cardioversion of atrial fibrillation
Disopyramide showed no clear difference in withdrawals due to adverse effects compared with placebo or no treatment (low certainty).
1 finding from 1 review
Proarrhythmia · adults in sinus rhythm after cardioversion of atrial fibrillation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Stroke · adults in sinus rhythm after cardioversion of atrial fibrillation
It is very uncertain whether disopyramide changes stroke compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Hospital mortality · patients with cardiogenic pulmonary oedema
NPPV may leads to lower HOSPITAL MORTALITY compared with SMC (low certainty).
1 finding from 1 review
ETI RATE · patients with cardiogenic pulmonary oedema
NPPV probably leads to lower ETI RATE compared with SMC (moderate certainty).
1 finding from 1 review
Myocardial infarction · patients with cardiogenic pulmonary oedema
NPPV showed no clear difference in ACUTE MI INCIDENCE compared with SMC (moderate certainty).
1 finding from 1 review
Length of hospital stay · patients with cardiogenic pulmonary oedema
1 finding from 1 review
Duration of ICU stay · patients with cardiogenic pulmonary oedema
1 finding from 1 review
Intolerance to allocated treatment · patients with cardiogenic pulmonary oedema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · patients with cardiogenic pulmonary oedema
1 finding from 1 review
Intervention not reported
Enrolment · adults (age 18 years or over) with myocardial infarction, stable angina, following coronary artery bypass graft surgery or percutaneous…
The intervention may leads to higher enrolment (low certainty).
1 finding from 1 review